Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02115555
Other study ID # IRB-04, IRB00000219
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date June 2016

Study information

Verified date February 2019
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will compare three treatment strategies to look at the best clinical outcomes.

The investigator hypothesizes that the combined approach of a health information technology program plus a conflict-management contract will lead to the best outcomes.


Description:

This study will compare three strategies for enhancing adherence to diabetes care in our population. The study will look at which strategy results in the best short-term clinical outcomes for the population. Also, the study will look at patient satisfaction of contact with his/her health care team, quality of life, and family dynamics.

The three arms are:

1. HIT (health information technology) aided approach

2. Contracted conflict-management strategy

3. Combination of the HIT-aided approach and the contracted conflict management strategy


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria:

- Type 1 diabetes diagnosed for at least 6 months

- At least one or more parent/guardian who agrees to participate

Exclusion Criteria:

- Other chronic diseases with the exception of well-controlled asthma or treated thyroid disease

Study Design


Intervention

Behavioral:
HIT-aided approach
Subjects randomized to this approach will be using the HIT-aided monitor.
Contracted conflict management system
Subjects randomized to this arm will be using the behavioral contracted conflict management system.
HIT plus contracted conflict management
Subjects randomized to this arm will use both the HIT-aided approach and the behavioral contract conflict management system.

Locations

Country Name City State
United States Riley Children's Specialties Carmel Indiana
United States Riley Children's Hospital Indianapolis Indiana

Sponsors (1)

Lead Sponsor Collaborator
Indiana University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Satisfaction Patient and parent satisfaction with the intervention with questions determined by the investigator. 3 month and 6 month
Primary Glycemic Control using HBA1C Change in Glycemic Control Baseline, 3 months, and 6 months
Secondary Frequency of self monitoring blood glucose measurement change in Self-monitoring blood glucose measurement Baseline, 3 months, 6 months
Secondary Quality of Life Change in Diabetes-specific quality of life measures will be measured by the Varney's Pediatric Quality of Life 3.0 Diabetes Module. Baseline and 6 months
Secondary Family dynamics Change in family dynamics measured by the Cornell Parent Behavior Description Scale and the Helping for Health Inventory. Baseline and 6 months
Secondary Treatment Adherence Behaviors Change in treatment adherence behaviors measured by the Self-Care Inventory with supplemental questions determined by the investigator. Once per month for 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02914886 - Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Phase 4
Completed NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany